Literature DB >> 25156543

The epidemiology of diabetes and cancer.

Bendix Carstensen1, Marit Eika Jørgensen, Søren Friis.   

Abstract

The literature on cancer occurrence in persons with diabetes has almost invariably been concerned with relative measures. In this paper, we briefly review this, but the aim is to quantify the absolute occurrence of diabetes and cancer in the population in order to give a fuller picture, which also includes the competing mortality risk. Overall, we find that some 35 % of the population will have a diagnosis of diabetes in their lifetime, 44 % a diagnosis of cancer, and about 15 % will have both diagnoses. The impact of differing mortality between persons with and without diabetes is illustrated by the fact that a person without diabetes at age 50 has a smaller lifetime risk of cancer than a person aged 50 with diabetes. Thus, the differences in cancer occurrence between persons with and without diabetes are of quantitatively smaller importance than the differences in mortality.

Entities:  

Mesh:

Year:  2014        PMID: 25156543     DOI: 10.1007/s11892-014-0535-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  18 in total

1.  Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment.

Authors:  Kristina Ranc; Marit E Jørgensen; Søren Friis; Bendix Carstensen
Journal:  Diabetologia       Date:  2014-03-15       Impact factor: 10.122

Review 2.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

3.  Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

Authors:  J A Johnson; S L Bowker; K Richardson; C A Marra
Journal:  Diabetologia       Date:  2011-07-12       Impact factor: 10.122

4.  The Danish Cancer Registry.

Authors:  Marianne Lundkjær Gjerstorff
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

5.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.

Authors:  L G Hemkens; U Grouven; R Bender; C Günster; S Gutschmidt; G W Selke; P T Sawicki
Journal:  Diabetologia       Date:  2009-06-30       Impact factor: 10.122

6.  Cancer risk in patients with diabetes mellitus.

Authors:  H O Adami; J McLaughlin; A Ekbom; C Berne; D Silverman; D Hacker; I Persson
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

7.  Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.

Authors:  Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

8.  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Authors:  C J Currie; C D Poole; E A M Gale
Journal:  Diabetologia       Date:  2009-07-02       Impact factor: 10.122

Review 9.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

10.  Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors:  H M Colhoun
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

View more
  13 in total

1.  Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama Study.

Authors:  Masahito Yoshinari; Yoichiro Hirakawa; Jun Hata; Mayu Higashioka; Takanori Honda; Daigo Yoshida; Naoko Mukai; Udai Nakamura; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Diabetologia       Date:  2021-04-28       Impact factor: 10.122

2.  Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.

Authors:  Christel Häggström; Mieke Van Hemelrijck; Björn Zethelius; David Robinson; Birgitta Grundmark; Lars Holmberg; Soffia Gudbjörnsdottir; Hans Garmo; Pär Stattin
Journal:  Int J Cancer       Date:  2016-11-03       Impact factor: 7.396

3.  Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Authors:  Dennis Schrijnders; Geertruida H de Bock; Sebastiaan T Houweling; Kornelis J J van Hateren; Klaas H Groenier; Jeffrey A Johnson; Henk J G Bilo; Nanne Kleefstra; Gijs W D Landman
Journal:  BMC Cancer       Date:  2017-06-23       Impact factor: 4.430

4.  Ensemble Learning Models Based on Noninvasive Features for Type 2 Diabetes Screening: Model Development and Validation.

Authors:  Tianzhou Yang; Li Zhang; Liwei Yi; Huawei Feng; Shimeng Li; Haoyu Chen; Junfeng Zhu; Jian Zhao; Yingyue Zeng; Hongsheng Liu
Journal:  JMIR Med Inform       Date:  2020-06-18

5.  Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis.

Authors:  Pei-Jung Lin; Elle Pope; Fang Liz Zhou
Journal:  Diabetes Ther       Date:  2018-08-10       Impact factor: 2.945

6.  Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016.

Authors:  Bendix Carstensen; Pernille Falberg Rønn; Marit Eika Jørgensen
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

7.  SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Nanjing Shi; Yetan Shi; Jingsi Xu; Yuexiu Si; Tong Yang; Mengting Zhang; Derry Minyao Ng; Xiangyuan Li; Fei Xie
Journal:  Front Public Health       Date:  2021-06-07

8.  Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).

Authors:  Dennis Schrijnders; Steven H Hendriks; Nanne Kleefstra; Pauline A J Vissers; Jeffrey A Johnson; Geertruida H de Bock; Henk J G Bilo; Gijs W D Landman
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

9.  Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy.

Authors:  Paola Ballotari; Massimo Vicentini; Valeria Manicardi; Marco Gallo; Sofia Chiatamone Ranieri; Marina Greci; Paolo Giorgi Rossi
Journal:  BMC Cancer       Date:  2017-10-25       Impact factor: 4.430

10.  Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus.

Authors:  Christel Häggström; Mieke Van Hemelrijck; Hans Garmo; David Robinson; Pär Stattin; Mark Rowley; Anthony C C Coolen; Lars Holmberg
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.